Shandong Sinobioway Soars 10.05%, Hits Intraday High of CNY 4.27

Shandong Sinobioway Biomedicine Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.05% on August 13, 2026. The stock reached an intraday high of CNY 4.27, marking a notable achievement in a challenging market environment. In comparison to the broader market, Shandong Sinobioway's one-day performance stands out against the China Shanghai Composite, which declined by 0.5%. Over the past week, the company has shown a robust increase of 24.49%, while its one-month performance reflects a gain of 17.63%. However, it is important to note that the stock has faced considerable challenges over the longer term, with a one-year decline of 42.84% and a staggering 75.96% drop over the past three years. Despite today's positive movement, the company continues to grapple with financial difficulties, including negative net worth and low management efficiency. As a small-cap player in the pharmaceuticals and biotechnology sector, Shandong Sinobioway's market cap stands at CNY 1,547 million, indicating its position within the industry.